Rigel Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of RIGL for the last quarter is 29.53 M USD, and it's 17.48% lower compared to the previous quarter. The net income of Q1 24 is -8.25 M USD.